News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Diego A. Díaz García: First RCT in NSCLC with uncommon EGFR mutations – Afatinib VS Chemotherapy
May 14, 2025, 13:10

Diego A. Díaz García: First RCT in NSCLC with uncommon EGFR mutations – Afatinib VS Chemotherapy

Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X about recent paper Satoru Miura and colleagues authored:

“First RCT in NSCLC with uncommon EGFR mutations: afatinib doubled PFS vs chemo (10.6 vs 5.7 mo).
ACHILLES/TORG1834 Should it be the new 1st-line standard?
Or could 3rd-gen TKIs novel combos do better?”
NSCLC

Title: Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834

Journal: Journal of Clinical Oncology

Authors: Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi, Hiroshige Yoshioka, Takaaki Tokito, Tatsuro Fukuhara, Yuki Sato, Yoshimasa Shiraishi, Katsuhiko Naoki, Hiroaki Akamatsu, Ou Yamaguchi, Toshihide Yokoyama, Shoichi Kuyama, Kazumi Nishino, Naoki Furuya, Takayasu Kurata, Terufumi Kato, Satoshi Ikeda, Hidehito Horinouchi, Eiki Ichihara, Masahide Mori, Yuichi Takiguchi, Kentaro Tanaka, Yasuhiro Goto, Hiroaki Okamoto

Read Full Article on ascopubs.org

Non-Small Cell Lung Cancer: Causes, Symptoms, Diagnosis, Treatment Options, and Latest 2025 Advances in Targeted and Immunotherapy

NSCLC Lung cancer
cancer Diego A. Díaz García Eiki Ichihara Hidehito Horinouchi Hiroaki Akamatsu Hiroaki Okamoto Hiroshi Tanaka Hiroshige Yoshioka Katsuhiko Naoki Kazumi Nishino Kentaro Tanaka Masahide Mori Naoki Furuya OncoDaily Oncology Ou Yamaguchi Satoru Miura Satoshi Ikeda Shoichi Kuyama Takaaki Tokito Takayasu Kurata Tatsuro Fukuhara Terufumi Kato Toshihide Yokoyama Toshihiro Misumi Yasuhiro Goto Yoshimasa Shiraishi Yuichi Takiguchi Yuki Sato
Special Coverage
Science
May 14, 2025, 13:10
Diego A. Díaz García: First RCT in NSCLC with uncommon EGFR mutations - Afatinib VS Chemotherapy
Blog
May 14, 2025, 13:10
Tanja Spanic: The Improving Cancer Outcomes and Leadership Course
Science
May 14, 2025, 13:01
George Vlachogiannis: Machine Learning Model Predicting Cardiac Readmissions in Blood Cancer Patients
Blog
May 14, 2025, 12:52
Apply for Travel Grants to attend ABC8 in Lisbon - ABC Global Alliance
Career
May 14, 2025, 12:48
Amanda Parkes Appointed Executive Medical Director of Early Development, Oncology at Amgen
Blog
May 14, 2025, 12:44
Laura Bukavina: Super Excited to Welcome Henning Plage to Cleveland Clinic Urology
Blog
May 14, 2025, 12:43
Emily Drake: Thrilled to be Appointed as Assistant Professor for Interdisciplinary Health Studies at Mount Allison University
Career
May 14, 2025, 12:35
Ophira Ginsburg Joins Médecins Sans Frontières as Consultant
Science
May 14, 2025, 12:34
Nelson Dusetti: The Use of Pancreas-View GEM to Personalize Adjuvant Chemotherapy and Improve Outcomes in PDAC
Insight
May 14, 2025, 12:23
Paco Arango Inaugurates Fundación Aladina Project at University Hospital of Toledo
Insight
May 14, 2025, 12:23
Kothari Rushabh: Phase 3 Study on Triple Metronomic Therapy Now Published in The Cancer Letter
Blog
May 14, 2025, 12:22
The ESO Masterclass: Autumn Edition